|
Volumn 87, Issue 12, 2007, Pages 802-805
|
Gene therapy of bladder cancer by using recombinant adeno-associated virus-endostatin: Experiments in vitro and in vivo
|
Author keywords
Angiogenesis inhibitors; Bladder neoplasms; Gene therapy
|
Indexed keywords
ENDOSTATIN;
PARVOVIRUS VECTOR;
YELLOW FLUORESCENT PROTEIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIANGIOGENIC ACTIVITY;
ANTIANGIOGENIC GENE THERAPY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLADDER CANCER;
BRAIN TISSUE;
CANCER CELL CULTURE;
CANCER GENE THERAPY;
CANCER INHIBITION;
CANCER SIZE;
CHEMOTAXIS;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
ENDOTHELIUM CELL;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GENETIC TRANSFECTION;
HEART;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
NUDE MOUSE;
SUPERNATANT;
UMBILICAL VEIN;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
VIRUS RECOMBINANT;
ANIMALS;
CELL LINE;
CELL LINE, TUMOR;
DEPENDOVIRUS;
ENDOSTATINS;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOVASCULARIZATION, PATHOLOGIC;
RANDOM ALLOCATION;
TRANSFECTION;
TUMOR BURDEN;
URINARY BLADDER NEOPLASMS;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 34249801521
PISSN: 03762491
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (8)
|